Sequenom


Stock Update (NASDAQ:SQNM): Sequenom, Inc. Welcomes Catherine J. Mackey, Ph.D., To Board Of Directors

Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that its …

Stock Update (NASDAQ:SQNM): Sequenom, Inc. Announces Private Exchange Transactions Regarding Outstanding Convertible Senior Notes

Sequenom, Inc. (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that it …

William Blair Comments On Sequenom In Light Of IP Settlement With Illumina

William Blair analyst Brian Weinstein reiterated an Outperfom rating on Sequenom (NASDAQ:SQNM), following the news that Sequenom and Illumina reached an agreement to settle all pending IP claims …

Oppenheimer Reiterates Outperform On Sequenom Following Patent Settlement With Illumina

Oppenheimer analyst Bret Jones reiterated an Outperform rating on Sequenom (NASDAQ:SQNM) with a $5.00 price target, as Sequenom and Illumina reached an agreement to settle all …

Oppenheimer Comments On Sequenom Following 3Q14 Results

Oppenheimer analyst Bret Jones maintained an Outperform rating on Sequenom (NASDAQ:SQNM) with a price target of $5.00, which represents a potential upside of …

William Blair Maintains Outperform On Sequenom Following 2Q14 Results

On Tuesday, July 29 Sequenom (SQNM) reported second quarter 2014 results that included revenue of $39.8 million, which was a bit shy of the consensus …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts